GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kineta Inc (STU:J75) » Definitions » Pre-Tax Income

Kineta (STU:J75) Pre-Tax Income : €-16.50 Mil (TTM As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Kineta Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Kineta's pretax income for the three months ended in Mar. 2024 was €-9.43 Mil. Its pretax income for the trailing twelve months (TTM) ended in Mar. 2024 was €-16.50 Mil. Kineta's pretax margin was %.

During the past 4 years, Kineta's highest Pretax Margin was -67.81%. The lowest was -6095.39%. And the median was -194.32%.


Kineta Pre-Tax Income Historical Data

The historical data trend for Kineta's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kineta Pre-Tax Income Chart

Kineta Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Pre-Tax Income
-5.85 -10.46 -59.90 -12.91

Kineta Quarterly Data
Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6.05 0.35 -4.98 -2.44 -9.43

Competitive Comparison of Kineta's Pre-Tax Income

For the Biotechnology subindustry, Kineta's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kineta's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Kineta's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Kineta's Pre-Tax Income falls into.



Kineta Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Kineta's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-14.418+1.521+-0.309+0.298+0
=-12.91

Kineta's Pretax Income for the quarter that ended in Mar. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-5.894+-3.541+-0.039+0.044+0.00099999999999945
=-9.43

Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-16.50 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kineta  (STU:J75) Pre-Tax Income Explanation

Kineta's Pretax Margin for the quarter that ended in Mar. 2024 is calculated as

Pretax Margin=Pretax Income/Revenue
=-9.429/0
=%

During the past 4 years, Kineta's highest Pretax Margin was -67.81%. The lowest was -6095.39%. And the median was -194.32%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kineta Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Kineta's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Kineta (STU:J75) Business Description

Traded in Other Exchanges
Address
219 Terry Avenue North, Suite 300, Seattle, WA, USA, 98109
Kineta Inc is a clinical-stage biotechnology company with a mission to develop next generation immunotherapies that transform patients' lives. The company's asset is KVA12.1, a VISTA blocking immunotherapy.

Kineta (STU:J75) Headlines

No Headlines